Skip to main content
. 2016 Jun 28;22(3):444–451. doi: 10.5056/jnm15192

Figure 3.

Figure 3

Kaplan-Meier estimates of idiopathic pulmonary fibrosis (IPF)-related mortality according to proton pump inhibitor (PPI) use. Green continuous line represents patients with PPI use over the cut-off value. Blue dotted line represents patients with PPI use for less than the cut-off value. (A) The cut-off value was 2 months, (B) 3 months, and (C) 4 months.